Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
603439.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
+130%
0.23
vs 0.1
Q1.23
+125%
0.14
vs 0.06
Q2.23
+14%
0.11
vs 0.1
Q3.23
+40%
0.14
vs 0.1
Q4.23
+44%
0.33
vs 0.23
Q1.24
+2%
0.14
vs 0.14
Q2.24
+31%
0.15
vs 0.11
Q3.24
+36%
0.19
vs 0.14
Q4.24
-42%
0.19
vs 0.33
Q1.25
-27%
0.1
vs 0.14
Sales Growth
YoY
Current
Estimates
Q4.22
+51%
491.2M vs 324.6M
Q1.23
+120%
349M vs 158.7M
Q2.23
+4%
281.7M vs 271.1M
Q3.23
+21%
338.8M vs 280.4M
Q4.23
+34%
658.9M vs 491.2M
Q1.24
+20%
417.4M vs 349M
Q2.24
+75%
492.5M vs 281.7M
Q3.24
+54%
521.3M vs 338.8M
Q4.24
+6%
697.3M vs 658.9M
Q1.25
-2%
408.6M vs 417.4M
Return on Equity
QoQ
Q2.23
+4%
0.04
vs 0.04
Q3.23
+4%
0.04
vs 0.04
Q4.23
+9%
0.09
vs 0.04
Q1.24
+4%
0.04
vs 0.09
Q2.24
+4%
0.04
vs 0.04
Q3.24
+5%
0.05
vs 0.04
Q4.24
+5%
0.05
vs 0.05
Q1.25
+3%
0.03
vs 0.05
Institutionnal Ownership
Quote Panel
Key Metrics
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.
SHH
0.44Â ( 3.38%)
Relative Strenght
Volume Buzz
1081%
Earning Acce
No
Dist 52w H.
18%Relative Strength
603439.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
613%2026-Revenue
800%2026-EPS
1047%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 603439.SS compares to sector?